N-Me-Phe(3)- morphiceptin (PL 17)

RN given refers to D-prolinamide, all L-isomer

Also Known As:

PL 17; PL17; morphiceptin, N-Me-Phe(3)-; 3-N-Me-Phe-morphiceptin; PL 017; PL-017; PL-17; Tyr-Pro-N-MePhe-Pro-NH2; morphiceptin, N-Me-Phe(3)-, all L-isomer; morphiceptin, N-methylphenylalanine(3)-; tyrosyl-prolyl-N-methylphenlalanyl-prolinamide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Opioid Peptides: 1339
        Endorphins: 977
        N-Me-Phe(3)- morphiceptin: 2
- Peptides: 82426
  - Neuropeptides: 6772
    - Opioid Peptides: 1339
      - Endorphins: 977
        N-Me-Phe(3)- morphiceptin: 2

Related Diseases

1.	Hyperthermia 12/01/1992 - "Hyperthermia, produced by PL-017 (1.86 nM) given ICV, resulted from increased Vo2 and reduced Q during the first 15-45 min postinjection. " 07/01/1995 - "NT (0.0747 nmol) had no effect on PL-017-induced hyperthermia; higher doses of PL-017/NT antagonized the hyperthermia and increased the peak and duration of the hypothermia. " 07/01/1995 - "PL-017 induced dose-dependent hyperthermia; NT, DY and U50 produced dose-related hypothermia. "
2.	Hypothermia 07/01/1995 - "NT (0.0747 nmol) had no effect on PL-017-induced hyperthermia; higher doses of PL-017/NT antagonized the hyperthermia and increased the peak and duration of the hypothermia. " 07/01/1995 - "PL-017 induced dose-dependent hyperthermia; NT, DY and U50 produced dose-related hypothermia. "